EcoDrugPlus

Aldose Reductase

Ensembl ID : ENSORLG00000010337
Gene Symbol: LOC101157022
3 Cross references
336 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSORLG00000008970
Gene Symbol: GAA
4 Cross references
234 Possible Orthologues:

Alpha-1a Adrenergic Receptor

Ensembl ID : ENSORLG00000005454
Gene Symbol: LOC101159926
3 Cross references
191 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSORLG00000000704
Gene Symbol: LOC101159125
3 Cross references
193 Possible Orthologues:

Alpha-2a Adrenergic Receptor-Like

Ensembl ID : ENSORLG00000005919
Gene Symbol: LOC101170540
3 Cross references
159 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSORLG00000024105
Gene Symbol: LOC101155866
3 Cross references
149 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSORLG00000004048
Gene Symbol: AOC1
4 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSORLG00000017488
Gene Symbol: AOC2
4 Cross references
403 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSORLG00000005026
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Amyloid-Beta A4 Protein

Ensembl ID : ENSORLG00000008914
Gene Symbol: LOC101172288
4 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSORLG00000009520
Gene Symbol: AR
3 Cross references
213 Possible Orthologues:

Androgen Receptor Beta

Ensembl ID : ENSORLG00000008220
Gene Symbol: AR-ALPHA
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).